The Cellular Thioredoxin-1/Thioredoxin Reductase-1 Driven Oxidoreduction Represents a Chemotherapeutic Target for HIV-1 Entry Inhibition
about
The Cellular Thioredoxin-1/Thioredoxin Reductase-1 Driven Oxidoreduction Represents a Chemotherapeutic Target for HIV-1 Entry Inhibition
description
2016 nî lūn-bûn
@nan
2016 թուականին հրատարակուած գիտական յօդուած
@hyw
2016 թվականին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
The Cellular Thioredoxin-1/Thi ...... get for HIV-1 Entry Inhibition
@ast
The Cellular Thioredoxin-1/Thi ...... get for HIV-1 Entry Inhibition
@en
The Cellular Thioredoxin-1/Thi ...... get for HIV-1 Entry Inhibition
@nl
type
label
The Cellular Thioredoxin-1/Thi ...... get for HIV-1 Entry Inhibition
@ast
The Cellular Thioredoxin-1/Thi ...... get for HIV-1 Entry Inhibition
@en
The Cellular Thioredoxin-1/Thi ...... get for HIV-1 Entry Inhibition
@nl
prefLabel
The Cellular Thioredoxin-1/Thi ...... get for HIV-1 Entry Inhibition
@ast
The Cellular Thioredoxin-1/Thi ...... get for HIV-1 Entry Inhibition
@en
The Cellular Thioredoxin-1/Thi ...... get for HIV-1 Entry Inhibition
@nl
P2093
P2860
P50
P1433
P1476
The Cellular Thioredoxin-1/Thi ...... get for HIV-1 Entry Inhibition
@en
P2093
Kathrin Reiser
Lars Engman
Leen Mathys
Mathias Lundberg
Sandra Liekens
Sophie Curbo
P2860
P304
P356
10.1371/JOURNAL.PONE.0147773
P407
P577
2016-01-01T00:00:00Z